CAIRDAC Announces the Appointment of Raymond W. Cohen as Chairman of its Board of Directors
CAIRDAC, a pre-revenue medtech developing the ALPS self-powered leadless pacemaker, appointed medtech veteran Raymond W. Cohen as chairman of its board. Cohen co-founded Axonics and led it to over $1.2 billion in revenue before its $3.7 billion sale to Boston Scientific in late 2024; he also guided the 2025 sales of SoniVie ($600 million) and Nalu Medical ($533 million). ALPS converts heartbeat mechanical energy into electricity via a piezoelectric harvester, targeting a ~$5.5 billion pacemaker market, with a first-in-human study and European CE-mark pathway planned ahead of a U.S.
Key figures
- Axonics revenue
- $1.2 billion
- Nalu sale value
- $533 million
- Sonivie sale value
- $600 million
- Pacemaker market size
- $5.5 billion
- Axonics acquisition value
- $3.7 billion
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.